Understanding REM Sleep Behavior Disorder through Functional MRI: A Systematic Review DOI Creative Commons
L. Churchill, Yu‐Chi Chen, Simon J.G. Lewis

и другие.

Movement Disorders, Год журнала: 2024, Номер 39(10), С. 1679 - 1696

Опубликована: Июнь 27, 2024

Abstract Neuroimaging studies in rapid eye movement sleep behavior disorder (RBD) can inform fundamental questions about the pathogenesis of Parkinson's disease (PD). Across modalities, functional magnetic resonance imaging (fMRI) may be better suited to identify changes between neural networks earliest stages Lewy body diseases when structural subtle or absent. This review synthesizes findings from all fMRI RBD gain further insight into pathophysiology and progression diseases. A total 32 were identified using a systematic conducted according PRISMA guidelines January 2000 February 2024 for original patients with either isolated (iRBD) secondary PD. Common alterations detectable iRBD compared healthy controls across brainstem nuclei, basal ganglia, frontal occipital lobes, whole brain network measures. Patients established PD demonstrated decreased connectivity but increased cerebellum lobe those without RBD. Finally, longitudinal resting state found track progression. Currently, have early signatures neurodegeneration both motor non‐motor pathways. Although more work is needed, such potential our understanding disease, help distinguish prodromal dementia bodies, support development fMRI‐based outcome measures phenoconversion future modifying trials. © The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf International Parkinson Disorder Society.

Язык: Английский

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies DOI Creative Commons
Xuxiang Zhang, Beisha Tang, Jifeng Guo

и другие.

Translational Neurodegeneration, Год журнала: 2023, Номер 12(1)

Опубликована: Дек. 15, 2023

Parkinson's disease (PD) is one of the most prevalent neurodegenerative diseases. The typical symptomatology PD includes motor symptoms; however, a range nonmotor symptoms, such as intestinal issues, usually occur before symptoms. Various microorganisms inhabiting gastrointestinal tract can profoundly influence physiopathology central nervous system through neurological, endocrine, and immune pathways involved in microbiota-gut-brain axis. In addition, extensive evidence suggests that gut microbiota strongly associated with PD. This review summarizes latest findings on microbial changes their clinical relevance, describes underlying mechanisms which bacteria may mediate PD, discusses correlations between microbes anti-PD drugs. this outlines status research therapies for future directions PD-gut research.

Язык: Английский

Процитировано

55

Brain-first vs. body-first Parkinson's disease: An update on recent evidence DOI Creative Commons
Jacob Horsager, Per Borghammer

Parkinsonism & Related Disorders, Год журнала: 2024, Номер 122, С. 106101 - 106101

Опубликована: Март 15, 2024

We recently proposed a new disease model of Parkinson's – the -Synuclein Origin site and Connectome model. The posits that initial pathology starts either in olfactory bulb or amygdala leading to brain-first subtype, enteric nervous system body-first subtype. These subtypes should be distinguishable early course on range imaging, clinical, neuropathological markers. Here, we review recent original human studies, which tested predictions model.Molecular imaging studies were generally agreement with model, whereas structural such as MRI volumetry, showed conflicting findings. Most large-scale clinical supportive, reporting clustering relevant markers including REM-sleep behavior disorder, constipation, autonomic dysfunction, neuropsychiatric symptoms, cognitive impairment. Finally, -synuclein deposition antemortem postmortem tissues revealed distribution pathology, supports

Язык: Английский

Процитировано

40

Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same DOI Creative Commons
Per Borghammer, Niels Okkels, Daniel Weintraub

и другие.

Journal of Parkinson s Disease, Год журнала: 2024, Номер 14(3), С. 383 - 397

Опубликована: Апрель 16, 2024

The question whether Parkinson’s disease dementia (PDD) and with Lewy bodies (DLB) are expressions of the same underlying has been vigorously debated for decades. recently proposed biological definitions body disease, which do not assign any particular importance to dopamine system over other degenerating neurotransmitter systems, once more brought discussion about different types forefront. Here, we briefly compare PDD DLB in terms their symptoms, imaging findings, neuropathology, ultimately finding them be indistinguishable. We then present a conceptual framework demonstrate how one can view clinical syndromes as manifestations shared disease. Early isolated RBD, pure autonomic failure perhaps even psychiatric represent diverse initial stages They characterized by heterogeneous comparatively limited neuronal dysfunction damage. In contrast, dementia, an encompassing term both DLB, represents uniform advanced stage Patients this category display extensive severe pathology, frequently accompanied co-existing pathologies, well multi-system degeneration. Thus, propose that should viewed single entity. Phenotypic variance is caused presence individual risk factors, mechanisms, co-pathologies. Distinct subtypes therefore defined subtype-specific mechanisms or biomarkers.

Язык: Английский

Процитировано

20

Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology DOI Creative Commons
Sophie E Mastenbroek, Jacob W. Vogel, Lyduine E. Collij

и другие.

Nature Communications, Год журнала: 2024, Номер 15(1)

Опубликована: Июнь 15, 2024

Lewy body (LB) diseases, characterized by the aggregation of misfolded α-synuclein proteins, exhibit notable clinical heterogeneity. This may be due to variations in accumulation patterns LB neuropathology. Here we apply a data-driven disease progression model regional neuropathological density scores from 814 brain donors with pathology. We describe three inferred trajectories pathology that are differing clinicopathological presentation and longitudinal antemortem progression. Most (81.9%) show earliest olfactory bulb, followed either limbic (60.8%) or brainstem (21.1%) regions. The remaining (18.1%) initially abnormalities Early is associated Alzheimer's disease-associated characteristics while early progressive motor impairment substantial outside brain. Our data provides evidence for heterogeneity temporal spread pathology, possibly explaining some disparities observed disease.

Язык: Английский

Процитировано

19

Predicting Parkinson’s Disease Using a Deep-Learning Algorithm to Analyze Prodromal Medical and Prescription Data DOI Creative Commons
Yong-Wan Koo, Minki Kim, Woong‐Woo Lee

и другие.

Journal of Clinical Neurology, Год журнала: 2025, Номер 21(1), С. 21 - 21

Опубликована: Янв. 1, 2025

Parkinson's disease (PD) is characterized by various prodromal symptoms, and these symptoms are mostly investigated retrospectively. While some such as rapid eye movement sleep behavior disorder highly specific, others common. This makes it challenging to predict those at risk of PD based solely on less-specific symptoms. The prediction accuracy when using only can be improved analyzing the vast amount information available sophisticated deep-learning techniques. study aimed improve performance deep-learning-based screening in detecting medical-claims data, including prescription information. We sampled 820 patients 8,200 age- sex-matched non-PD controls from Korean National Health Insurance cohort data. A algorithm was developed combinations diagnostic codes, medication periods. During period year -3 0, predicting codes yielded a high 0.937. Adding for same did not increase (0.931-0.935). For earlier (year -6 -3), decreased 0.890 codes. inclusion all medication-codes data increased that markedly 0.922. both effective PD. Developing surveillance system with automatically collected developing could cost-effective. approach streamline process disease-modifying drugs focusing most-appropriate candidates accurate tests.

Язык: Английский

Процитировано

3

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective DOI
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi

и другие.

Probiotics and Antimicrobial Proteins, Год журнала: 2025, Номер unknown

Опубликована: Янв. 15, 2025

Язык: Английский

Процитировано

3

Inflammatory bowel disease induces pathological α‐synuclein aggregation in the human gut and brain DOI Creative Commons
Ana M. Espinosa‐Oliva, Rocío Ruiz, Manuel Sarmiento Soto

и другие.

Neuropathology and Applied Neurobiology, Год журнала: 2024, Номер 50(1)

Опубликована: Фев. 1, 2024

Abstract Aims According to Braak's hypothesis, it is plausible that Parkinson's disease (PD) originates in the enteric nervous system (ENS) and spreads brain through vagus nerve. In this work, we studied whether inflammatory bowel diseases (IBDs) humans can progress with emergence of pathogenic α‐synuclein (α‐syn) gastrointestinal tract midbrain dopaminergic neurons. Methods We have analysed gut ventral from subjects previously diagnosed IBD form a DSS‐based rat model inflammation terms α‐syn pathology. Results Our data support existence both brain, thus reinforcing potential role ENS as contributing factor PD aetiology. Additionally, effect demonstrate (i) appearance P‐α‐syn inclusions Auerbach's Meissner's plexuses (gut), (ii) an increase expression mesencephalon (brain) (iii) degeneration nigral neurons, which all are considered classical hallmarks PD. Conclusion These results strongly plausibility hypothesis emphasise significance peripheral gut‐brain axis initiating aggregation transport substantia nigra, resulting neurodegeneration.

Язык: Английский

Процитировано

18

A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs DOI Creative Commons
Haley Geertsma, Zoe Fisk,

Lillian Sauline

и другие.

npj Parkinson s Disease, Год журнала: 2024, Номер 10(1)

Опубликована: Март 19, 2024

Parkinson's disease (PD) is the second most common neurodegenerative worldwide and presents pathologically with Lewy pathology dopaminergic neurodegeneration. contains aggregated α-synuclein (αSyn), a protein encoded by SNCA gene which also mutated or duplicated in subset of familial PD cases. Due to its predominant presynaptic localization, immunostaining for results diffuse reactivity pattern, providing little insight into types cells expressing αSyn. As result, αSyn expression-driven cellular vulnerability has been difficult ascertain. Using combination knock-in mice that target nucleus (Snca

Язык: Английский

Процитировано

17

Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes DOI
Niels Okkels, Michel J. Grothe, John‐Paul Taylor

и другие.

Brain, Год журнала: 2024, Номер 147(7), С. 2308 - 2324

Опубликована: Фев. 29, 2024

Cholinergic degeneration is significant in Lewy body disease, including Parkinson's dementia with bodies, and isolated REM sleep behaviour disorder. Extensive research has demonstrated cholinergic alterations the CNS of these disorders. More recently, studies have revealed denervation organs that receive parasympathetic denervation. This enables a comprehensive review changes encompassing both central peripheral regions, various disease stages diagnostic categories. Across studies, brain regions affected show equal or greater levels impairment compared to without dementia. observation suggests continuum between Patients exhibit relative sparing limbic whereas occipital superior temporal appear be similar extent patients implies posterior cell groups basal forebrain are early disorders, while more anterior typically later progression. The topographical observed by comorbid Alzheimer pathology may reflect combination seen pure forms those Alzheimer's disease. co-pathology important understand Thalamic innervation dementia, this contribute distinct clinical presentations groups. In thalamus variably affected, suggesting different sequential involvement disorder demonstrate abdominal from dorsal motor nucleus vagus, who experienced their prodrome. for understanding prodromal manifest phases conclusion, carry implications phenotypes influence co-pathology, delineating subtypes pathological spreading routes, developing tailored treatments targeting system.

Язык: Английский

Процитировано

15

The Body, the Brain, the Environment, and Parkinson’s Disease DOI
E. Ray Dorsey, Briana R. De Miranda, Jacob Horsager

и другие.

Journal of Parkinson s Disease, Год журнала: 2024, Номер 14(3), С. 363 - 381

Опубликована: Апрель 9, 2024

The brain- and body-first models of Lewy body disorders predict that aggregated alpha-synuclein pathology usually begins in either the olfactory system or enteric nervous system. In both scenarios seems to arise structures are closely connected outside world. Environmental toxicants, including certain pesticides, industrial chemicals, air pollution therefore plausible trigger mechanisms for Parkinson’s disease dementia with bodies. Here, we propose toxicants inhaled through nose can lead pathological changes subsequently spread give rise a brain-first subtype disease. Similarly, ingested pass gut cause then extends via parasympathetic sympathetic pathways ultimately produce subtype. resulting be tracked by development symptoms, clinical assessments, vivo imaging, examination. integration environmental exposures into generates testable hypotheses, on prevalence conditions, their future incidence, imaging patterns, signatures. proposed link, though, has limitations leaves many questions unanswered, such as role skin, influence microbiome, effects ongoing exposures. Despite these limitations, interaction exogenous factors may explain mysteries open door toward ultimate goal –prevention.

Язык: Английский

Процитировано

14